Objectives
To understand future biologic use / treatment selection dynamics amongst moderate-to-severe asthma patients as well as to inform PRODUCT X’s opportunities, risks, and positioning in an increasingly crowded asthma space.
Scope
Methodology
Conduct quantitative research with n=320 allergists, pulmonologists, and pediatric pulmonologists to collect ~1,400 asthma patient charts as well as n=40 qualitative research discussions. Execute against complex statistical analyses to uncover underlying treatment selection drivers and the evolution of future positioning.
Deliverables
- Underlying asthma subtype definition framework and stratification
- Identification of drivers in asthma biologic treatment selection
- Projected future market shares of asthma biologics
- Future PRODUCT X target patient evolution
- PRODUCT X positioning insights and strategy
Illustrative Outputs
Impact
CBPartners helped the PRODUCT X client team map the evolution of the asthma landscape as well as define future positioning tactics to help them compete in a crowded space.